D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
+$490M |
| 2 |
Microsoft
MSFT
|
+$461M |
| 3 |
Estee Lauder
EL
|
+$422M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$239M |
| 5 |
Nike
NKE
|
+$234M |
Top Sells
| 1 |
Walmart
WMT
|
+$585M |
| 2 |
Tesla
TSLA
|
+$470M |
| 3 |
NVIDIA
NVDA
|
+$431M |
| 4 |
Eli Lilly
LLY
|
+$360M |
| 5 |
T-Mobile US
TMUS
|
+$299M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Consumer Discretionary | 14.71% |
| 3 | Healthcare | 12.37% |
| 4 | Financials | 8.93% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Treace Medical Concepts
TMCI
$456M
| $895K | ﹤0.01% |
68,249
-172,714
| -72% | -$2.26M |
|
1952
Vistra
VST
$72.3B
| $894K | ﹤0.01% |
26,932
+4,649
| +21% | +$154K |
|
1953
Inspired Entertainment
INSE
$251M
| $893K | ﹤0.01% |
74,641
-54,844
| -42% | -$656K |
|
1954
Helios Technologies
HLIO
$1.8B
| $892K | ﹤0.01% |
16,086
-5,078
| -24% | -$282K |
|
|
INST
1955
DELISTED
Instructure Holdings, Inc.
INST
| $891K | ﹤0.01% |
35,075
-3,220
| -8% | -$81.8K |
|
1956
Comfort Systems
FIX
$27.6B
| $891K | ﹤0.01% |
5,228
-5,307
| -50% | -$904K |
|
1957
Sight Sciences
SGHT
$184M
| $885K | ﹤0.01% |
262,693
+37,127
| +16% | +$125K |
|
1958
Scilex Holding
SCLX
$179M
| $878K | ﹤0.01% |
17,915
| – | – |
|
1959
eHealth
EHTH
$120M
| $877K | ﹤0.01% |
118,486
-109,566
| -48% | -$811K |
|
|
SWI
1960
DELISTED
SolarWinds Corporation Common Stock
SWI
| $876K | ﹤0.01% |
92,834
-25,260
| -21% | -$238K |
|
1961
AvidXchange
AVDX
$2.06B
| $876K | ﹤0.01% |
92,430
-798,662
| -90% | -$7.57M |
|
1962
Papa John's
PZZA
$1.63B
| $874K | ﹤0.01% |
+12,816
| New | +$874K |
|
1963
Park Hotels & Resorts
PK
$2.41B
| $874K | ﹤0.01% |
70,905
-145,432
| -67% | -$1.79M |
|
|
RENE
1964
DELISTED
Cartesian Growth Corp II
RENE
| $864K | ﹤0.01% |
80,000
| – | – |
|
1965
Madrigal Pharmaceuticals
MDGL
$9.49B
| $864K | ﹤0.01% |
5,914
+316
| +6% | +$46.1K |
|
1966
Avista
AVA
$2.92B
| $861K | ﹤0.01% |
26,600
+19,900
| +297% | +$644K |
|
|
YALA
1967
Yalla Group
YALA
$1.2B
| $859K | ﹤0.01% |
164,025
+64,447
| +65% | +$338K |
|
1968
Lexicon Pharmaceuticals
LXRX
$407M
| $855K | ﹤0.01% |
784,122
-429,604
| -35% | -$468K |
|
1969
Independent Bank
INDB
$3.54B
| $851K | ﹤0.01% |
17,333
-6,491
| -27% | -$319K |
|
1970
Pliant Therapeutics
PLRX
$93.9M
| $850K | ﹤0.01% |
48,999
-369,664
| -88% | -$6.41M |
|
1971
Informatica
INFA
$7.56B
| $843K | ﹤0.01% |
40,012
+23,426
| +141% | +$494K |
|
1972
Halozyme
HALO
$8.93B
| $842K | ﹤0.01% |
22,049
+10,849
| +97% | +$414K |
|
|
RENT
1973
Rent the Runway
RENT
$19.9M
| $839K | ﹤0.01% |
61,662
-28,113
| -31% | -$383K |
|
1974
Oak Woods Acquisition Corp
OAKU
$63.2M
| $836K | ﹤0.01% |
80,000
| – | – |
|
1975
Karyopharm Therapeutics
KPTI
$54.3M
| $835K | ﹤0.01% |
41,524
+1,673
| +4% | +$33.6K |
|